英特格拉生命科学 IART 深 沪
等待开盘 10-06 09:30:00 美东时间
13.29
+0.610
+4.81%
华盛通- 最 高17.33
- 今 开12.60
- 成交量 185.06万股
- 最 低 12.36
- 昨 收 12.68
- 总市值 110.49万
- 52周最高 20.49
- 市盈率 静 6.72
- 换手率 2226.06%
- 52周最低 8.70
- 委 比 -39.48%
- 总股本 8.31万
- 历史最高 77.40
- 量 比 1.73
- 振 幅 39.20%
- 历史最低 1.10
- 每 手 1
- 风险率 2.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Integra LifeSciences Enrolls 100th Participant In Its AERA Pediatric Registry Observational Registry
Integra LifeSciences (Nasdaq: IART), a leading global medical technology company, announced today the enrollment of the 100th patient in the AERA® Pediatric Registry, a prospective, multicenter observational registry
09-29 20:32
Argus Research Downgrades Integra Lifesciences to Hold
Argus Research analyst David Toung downgrades Integra Lifesciences (NASDAQ:IART) from Buy to Hold.
04-15 19:46
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
FDA Issues Alert For Integra Wound Care Products Over Infection Fears
FDA warns of high-risk device issue with wound and burn care products by Integra LifeSciences, citing infection risks.
01-24 01:22
Expert Outlook: Integra Lifesciences Through The Eyes Of 8 Analysts
Integra Lifesciences (NASDAQ:IART) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the pr...
2024-08-23 00:00
Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $20
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $23 to $20.
2024-08-22 23:52
